Scopus BioPharma has licensed a gene-silencing drug from California’s City of Hope hospital that is due to start clinical testing in lymphoma patients later this year. The gene therapy – known ...

Financial Health for Scopus is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets. Loading view data ...